Incyte Announces that the REACH2 Pivotal Trial of Ruxolitinib (Jakafi) Meets Primary Endpoint in Patients with Steroid-Refractory Acute…
Posted: October 16, 2019 at 7:52 pm
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) today announced positive results from the Novartis-sponsored pivotal Phase 3 REACH2 study evaluating ruxolitinib (Jakafi) in patients with steroid-refractory acute graft-versus-host disease (GVHD). The study met its primary endpoint of improving overall response rate (ORR) at Day 28 with ruxolitinib treatment compared to best available therapy. No new safety signals were observed, and the ruxolitinib safety profile in REACH2 was consistent with that seen in previously reported studies in steroid-refractory acute GVHD.
Further analysis of the safety and efficacy data is ongoing. Novartis expects to initiate discussions with ex-U.S. regulatory authorities in 2020, and to submit REACH2 results for presentation at an upcoming scientific meeting.
GVHD is a challenging and serious disease, and physicians around the world need access to therapies that can improve outcomes for patients, said Peter Langmuir, M.D., Group Vice President, Targeted Therapies, Incyte. This positive result of the REACH2 study is excellent news for patients as it further reinforces the potential of ruxolitinib as a treatment option that can provide meaningful results for patients with steroid-refractory acute GVHD.
GVHD is a condition that can occur after an allogeneic transplant (the transfer of stem cells from a donor) where the donated cells initiate an immune response and attack the transplant recipients organs, leading to significant morbidity and mortality. There are two major forms of GVHD, acute and chronic, that can affect multiple organ systems including the skin, gastrointestinal (digestive) tract and liver.
Earlier this year, Jakafi was approved by the U.S. Food and Drug Administration (FDA) for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years and older based on results of the REACH1 trial. Jakafi is marketed by Incyte in the U.S.; ruxolitinib (Jakavi) is licensed to Novartis ex-U.S.
In addition, the pivotal REACH3 trial evaluating ruxolitinib in patients with steroid-refractory chronic GVHD is ongoing. A recent interim efficacy and safety analysis conducted by an Independent Data Monitoring Committee has recommended that REACH3, which is co-sponsored by Incyte and Novartis, should continue without modification. The results of the REACH3 trial are expected to be available in 2020.
About REACH2
REACH2 (NCT02913261) is a randomized, open-label, multicenter Phase 3 study sponsored by Novartis, evaluating safety and efficacy of ruxolitinib compared with best available therapy in patients with steroid-refractory acute GVHD.
The primary endpoint was overall response rate (ORR) at Day 28, defined as the proportion of patients demonstrating a best overall response (complete response or partial response). Secondary endpoints include durable ORR at Day 56, ORR at Day 14, duration of response, overall survival and event-free survival, among others. For more information about the study, please visit https://clinicaltrials.gov/ct2/show/NCT02913261.
About REACH
The REACH clinical trial program is evaluating Jakafi in patients with steroid-refractory GVHD and includes the collaborative Novartis-sponsored randomized pivotal Phase 3 trials: REACH2 and REACH3. The ongoing REACH3 trial is evaluating patients with steroid-refractory chronic GVHD with results expected next year. For more information about the REACH3 study, please visit https://clinicaltrials.gov/ct2/show/NCT03112603.
The REACH program was initiated with the Incyte-sponsored REACH1 trial, a prospective, open-label, single-cohort, multicenter, pivotal Phase 2 trial (NCT02953678) evaluating Jakafi in combination with corticosteroids in patients with steroid-refractory grade II-IV acute GVHD. For more information about the study, including trial results, please visit https://clinicaltrials.gov/show/NCT02953678.
About Jakafi (ruxolitinib)
Jakafi is a first-in-class JAK1/JAK2 inhibitor approved by the U.S. FDA for treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years and older.
Jakafi is also indicated for treatment of polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea as well as adults with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF.
Jakafi is marketed by Incyte in the United States and by Novartis as Jakavi (ruxolitinib) outside the United States. Jakafi is a registered trademark of Incyte Corporation. Jakavi is a registered trademark of Novartis AG in countries outside the United States.
Important Safety Information
Jakafi can cause serious side effects, including:
Low blood counts: Jakafi (ruxolitinib) may cause your platelet, red blood cell, or white blood cell counts to be lowered. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will perform blood tests to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you develop or have worsening symptoms such as unusual bleeding, bruising, tiredness, shortness of breath, or a fever.
Infection: You may be at risk for developing a serious infection during treatment with Jakafi. Tell your healthcare provider if you develop any of the following symptoms of infection: chills, nausea, vomiting, aches, weakness, fever, painful skin rash or blisters.
Skin cancers: Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Tell your healthcare provider if you develop any new or changing skin lesions.
Increases in cholesterol: You may have changes in your blood cholesterol levels. Your healthcare provider will do blood tests to check your cholesterol levels during your treatment with Jakafi.
The most common side effects of Jakafi include: for certain types of MF and PV - low platelet count, low red blood cell count, bruising, dizziness, and headache; and for acute GVHD low red blood cell counts, low platelet counts, low white blood cell counts, infections and fluid retention.
These are not all the possible side effects of Jakafi. Ask your pharmacist or healthcare provider for more information. Tell your healthcare provider about any side effect that bothers you or that does not go away.
Before taking Jakafi, tell your healthcare provider about: all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had tuberculosis (TB), or have been in close contact with someone who has TB, have or had hepatitis B, have or had liver or kidney problems, are on dialysis, have a high level of fat in your blood (high blood cholesterol or triglycerides), had skin cancer or have any other medical condition. Take Jakafi exactly as your healthcare provider tells you. Do not change or stop taking Jakafi without first talking to your healthcare provider.
Women should not take Jakafi while pregnant or planning to become pregnant. Do not breast-feed during treatment with Jakafi and for 2 weeks after the final dose.
Full Prescribing Information, which includes a more complete discussion of the risks associated with Jakafi, is available at http://www.jakafi.com.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Companys website at http://www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
Forward Looking Statements
Except for the historical information set forth herein, the matters set forth in this press release, including statements regarding whether and when the REACH2 data will be presented, when results from the REACH3 study will be available, and the effect of the REACH2 results on patients with GVHD, contain predictions, estimates and other forward-looking statements.
These forward-looking statements are based on the Companys current expectations and subject to risks and uncertainties that may cause actual results to differ materially, including unanticipated developments in and risks related to: unanticipated delays; further research and development and the results of clinical trials possibly being unsuccessful or insufficient to meet applicable regulatory standards or warrant continued development; the ability to enroll sufficient numbers of subjects in clinical trials; determinations made by the FDA; the Companys dependence on its relationships with its collaboration partners; the efficacy or safety of the Companys products and the products of the Companys collaboration partners; the acceptance of the Companys products and the products of the Companys collaboration partners in the marketplace; market competition; sales, marketing, manufacturing and distribution requirements; greater than expected expenses; expenses relating to litigation or strategic activities; and other risks detailed from time to time in the Companys reports filed with the Securities and Exchange Commission, including its Form 10-Q for the quarter ended June 30, 2019. The Company disclaims any intent or obligation to update these forward-looking statements.
- Secret History of Diamonds Narrated for the Visually Impaired - Part 2 of 4 [Last Updated On: June 24th, 2011] [Originally Added On: June 24th, 2011]
- Skin Stem Cells: Their Biology [Last Updated On: June 24th, 2011] [Originally Added On: June 24th, 2011]
- Emerge Labs New Anti Aging Swiss Apple Stem Cell Skin Care [Last Updated On: June 25th, 2011] [Originally Added On: June 25th, 2011]
- No Avastin for Breast Cancer [Last Updated On: June 25th, 2011] [Originally Added On: June 25th, 2011]
- Signals Skincare System [Last Updated On: June 25th, 2011] [Originally Added On: June 25th, 2011]
- Signals Skincare System [Last Updated On: June 25th, 2011] [Originally Added On: June 25th, 2011]
- Growing Nerve Cells [Last Updated On: June 26th, 2011] [Originally Added On: June 26th, 2011]
- Elaine Fuchs Part 2: Tapping the Potential of Adult Stem Cells, and Summary [Last Updated On: June 26th, 2011] [Originally Added On: June 26th, 2011]
- A Major Breakthrough in Skin Care and Nutrition [Last Updated On: June 27th, 2011] [Originally Added On: June 27th, 2011]
- Stem Cell Facial At Metamorphosis Day Spa Using Emerge Labs Skin Care [Last Updated On: June 27th, 2011] [Originally Added On: June 27th, 2011]
- Come Back Kid [Last Updated On: June 28th, 2011] [Originally Added On: June 28th, 2011]
- PhytoCell.mp4 [Last Updated On: June 28th, 2011] [Originally Added On: June 28th, 2011]
- When Beauty Calls: The Link between Science and Skin Care [Last Updated On: June 29th, 2011] [Originally Added On: June 29th, 2011]
- Skin Stem Cells: Their Biology [Last Updated On: June 29th, 2011] [Originally Added On: June 29th, 2011]
- Come Back Kid [Last Updated On: July 1st, 2011] [Originally Added On: July 1st, 2011]
- PhytoCell.mp4 [Last Updated On: July 1st, 2011] [Originally Added On: July 1st, 2011]
- The Skin Gun stem cell research [Last Updated On: July 1st, 2011] [Originally Added On: July 1st, 2011]
- World's 1st Nutricosmetic with Stem Cell Nutrients [Last Updated On: July 2nd, 2011] [Originally Added On: July 2nd, 2011]
- NG Raccoon Attack [Last Updated On: July 3rd, 2011] [Originally Added On: July 3rd, 2011]
- No Avastin for Breast Cancer [Last Updated On: July 4th, 2011] [Originally Added On: July 4th, 2011]
- E'shee HBA Global Expo 2011, NYC. Skin Care Anti-Aging Symposium [Last Updated On: July 5th, 2011] [Originally Added On: July 5th, 2011]
- Growing Nerve Cells [Last Updated On: July 9th, 2011] [Originally Added On: July 9th, 2011]
- The Skin Gun [Last Updated On: July 9th, 2011] [Originally Added On: July 9th, 2011]
- E'shee HBA Global Expo 2011, NYC. Skin Care Anti-Aging Symposium [Last Updated On: July 14th, 2011] [Originally Added On: July 14th, 2011]
- A Major Breakthrough in Skin Care and Nutrition [Last Updated On: July 17th, 2011] [Originally Added On: July 17th, 2011]
- Elaine Fuchs Part 1: Introduction to Stem Cells [Last Updated On: July 20th, 2011] [Originally Added On: July 20th, 2011]
- World's 1st Nutricosmetic with Stem Cell Nutrients [Last Updated On: July 21st, 2011] [Originally Added On: July 21st, 2011]
- Stem cells acquired from human skin [Last Updated On: August 9th, 2011] [Originally Added On: August 9th, 2011]
- Stem cells acquired from human skin [Last Updated On: August 17th, 2011] [Originally Added On: August 17th, 2011]
- DermaStem Renewal Serum - Stem Cells for Your Skin from STEMTech - New Paradigm in Beauty! [Last Updated On: August 19th, 2011] [Originally Added On: August 19th, 2011]
- DermaStem Renewal Serum - Stem Cells for Your Skin from STEMTech - New Paradigm in Beauty! [Last Updated On: August 30th, 2011] [Originally Added On: August 30th, 2011]
- ReLuma-stemcells- skin rejuvenation [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Dr Nathan Newman- Formulator of Stem Cell Skin Care Line LUMINESCE [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Genetic Skin Disease (EB): Spotlight on Stem Cell Research - Patient Advocate [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Genetic Skin Disease (EB): Spotlight on Stem Cell Research - Patient Advocate [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Stem Cell Skin Care- What is the role of stem cells in Luminesce Featuring Dr Nathan Newman [Last Updated On: September 7th, 2011] [Originally Added On: September 7th, 2011]
- Luminesce Stem Cell Skin Care - Leaders in Jeunesse [Last Updated On: September 7th, 2011] [Originally Added On: September 7th, 2011]
- The Skin Gun (Stem Cell research to replace burnt off skin. Done in 3 days!) [Last Updated On: September 7th, 2011] [Originally Added On: September 7th, 2011]
- Stem Cell Skin Care- What is the role of stem cells in Luminesce Featuring Dr Nathan Newman [Last Updated On: September 7th, 2011] [Originally Added On: September 7th, 2011]
- Isolation and Culture of Adult Epithelial Stem Cells from Human Skin [Last Updated On: September 9th, 2011] [Originally Added On: September 9th, 2011]
- Genetic Skin Disease (EB): Spotlight on Stem Cell Research - Welcome [Last Updated On: September 9th, 2011] [Originally Added On: September 9th, 2011]
- Stem Cells Made From Human Skin [Last Updated On: September 9th, 2011] [Originally Added On: September 9th, 2011]
- Jeunesse Global Business Opportunity with Stem Cell Skin Care Developed by Dr Nathan Newman [Last Updated On: September 10th, 2011] [Originally Added On: September 10th, 2011]
- Stem Cell Therapy Skin Repair and Anti-Wrinkle Cream [Last Updated On: September 10th, 2011] [Originally Added On: September 10th, 2011]
- Stem Cells Made From Human Skin [Last Updated On: September 10th, 2011] [Originally Added On: September 10th, 2011]
- Genetic Skin Disease (EB): Optimizing Embryonic Stem Cell Differentiation Protocols [Last Updated On: September 10th, 2011] [Originally Added On: September 10th, 2011]
- Genetic Skin Disease (EB): Spotlight on Stem Cell Research - Introduction [Last Updated On: September 11th, 2011] [Originally Added On: September 11th, 2011]
- Isolation and Culture of Adult Epithelial Stem Cells from Human Skin [Last Updated On: September 11th, 2011] [Originally Added On: September 11th, 2011]
- Stem Cell Therapy - BioLogic Anti-Aging Skin Cream [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- Best natural skin care serum using stem cell technology [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- Jeunesse Global Business Opportunity with Stem Cell Skin Care Developed by Dr Nathan Newman [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- Genetic Skin Disease (EB): Optimizing Embryonic Stem Cell Differentiation Protocols [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- The Skin Gun (Stem Cell research to replace burnt off skin. Done in 3 days!) [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- Research on skin cancer: ERC funds studies on stem cells [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Skin engineering [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Stem Cell Banking: The Perspective of an iPS Donor Family [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Jeunesse Global Opportunity- Stem Cell Skin Care [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Dr Nathan Newman Repairs Laugh Lines With Stem Cell Face Lift [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Dr Nathan Newman MD Stem Cell Face lift On Extra TV.flv [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Dr Nathan Newman Stem Cell Face Lift on Entertainment Tonight [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Dr Nathan Newman MD Stem Cell Face lift On Good Morning LA.flv [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Ellis Martin Report with International Stem Cell Corp [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- Dr Nathan Newman MD Stem Cell Face lift on Channel 7 KABC.flv [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- Stem Cell Face Treatment - What People Are Saying | Beverly Hills | Los Angeles [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- How To Use Your Stem Cells For Facial Skin Rejuvenation [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- StemCellTV - From National Geographic - The Skin Gun - Healing Burns with Stem Cells [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- AMAZING - Stem Cell Skin Cream And Liquid Face Lift Revealed [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Care for Your Skin with Lifeline Skin Care [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- For Damaged Skin - Rejuvenate Your Own Stem Cells [Last Updated On: September 26th, 2011] [Originally Added On: September 26th, 2011]
- Stem Cells: Fulfilling the Promise - 2011 CIRM Grantee Meeting [Last Updated On: September 28th, 2011] [Originally Added On: September 28th, 2011]
- Dr.Thomas Barnes' PRP Hair Growth and Skin Rejuvenation [Last Updated On: September 28th, 2011] [Originally Added On: September 28th, 2011]
- Stem Cell Face Lift - English (Part 5) [Last Updated On: September 28th, 2011] [Originally Added On: September 28th, 2011]
- Dr Amiya Prasad discusses ACell for Hair Regrowth and Skin Rejuvenation with EYES IN Magazine [Last Updated On: September 30th, 2011] [Originally Added On: September 30th, 2011]
- Brussels scientist close to discovering skin cancer origins [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- Cell Reprogramming Transformed [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- Cell Reprogramming Transformed [Last Updated On: October 7th, 2011] [Originally Added On: October 7th, 2011]
- Elaine Fuchs Part 1: Introduction to Stem Cells English Subtitle [Last Updated On: October 10th, 2011] [Originally Added On: October 10th, 2011]
- Elaine Fuchs Part 1: Introduction to Stem Cells English Subtitle [Last Updated On: October 13th, 2011] [Originally Added On: October 13th, 2011]
- Elaine Fuchs discusses research on skin and adult stem cells - Video [Last Updated On: October 13th, 2011] [Originally Added On: October 13th, 2011]
- Signals Stem Cell Skin Care Anti Aging Skin Care - Video [Last Updated On: October 13th, 2011] [Originally Added On: October 13th, 2011]